News Releases

30 Nov 2017
BioTelemetry, Inc. Enters Agreement to Provide Cardiac Monitoring for Apple’s Heart Study
MALVERN, Pa. , Nov. 30, 2017 (GLOBE NEWSWIRE) -- BioTelemetry, Inc. (NASDAQ:BEAT), the leading mobile and wireless medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care, announced today a partnership with Apple (NASDAQ:AAPL) to
27 Nov 2017
Telcare, a Division of BioTelemetry, Inc., Announces Collaboration with Onduo in Diabetes Management Program
MALVERN, Pa. , Nov. 27, 2017 (GLOBE NEWSWIRE) -- (NASDAQ:BEAT) – Telcare, the manufacturer of the world’s first FDA -cleared cellular-enabled blood glucose monitor, has entered into a strategic collaboration with Onduo, a joint venture created by Verily (an Alphabet company) and Sanofi .
07 Nov 2017
BioTelemetry, Inc. Reports Third Quarter 2017 Financial Results
Company Posts Strong Growth with Integration Ahead of Schedule  Reports Record Quarterly Revenue and Adjusted EBITDA MALVERN, Pa. , Nov. 07, 2017 (GLOBE NEWSWIRE) -- BioTelemetry, Inc. (NASDAQ:BEAT), the leading mobile and wireless medical technology company focused on the delivery of health